GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SillaJen Inc (XKRX:215600) » Definitions » Total Equity

SillaJen (XKRX:215600) Total Equity : ₩131,817 Mil (As of Dec. 2024)


View and export this data going back to 2016. Start your Free Trial

What is SillaJen Total Equity?

SillaJen's total equity for the quarter that ended in Dec. 2024 was ₩131,817 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


SillaJen Total Equity Historical Data

The historical data trend for SillaJen's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SillaJen Total Equity Chart

SillaJen Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22,879.74 108,048.08 78,939.49 57,313.96 131,817.27

SillaJen Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 57,313.96 52,129.88 146,746.44 138,763.06 131,817.27

SillaJen Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

SillaJen's Total Equity for the fiscal year that ended in Dec. 2024 is calculated as

Total Equity=Total Assets(Q: Dec. 2024 )-Total Liabilities(Q: Dec. 2024 )
=149015.779-17198.51
=131,817

SillaJen's Total Equity for the quarter that ended in Dec. 2024 is calculated as

Total Equity=Total Assets(Q: Dec. 2024 )-Total Liabilities(Q: Dec. 2024 )
=149015.779-17198.51
=131,817

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SillaJen Total Equity Related Terms

Thank you for viewing the detailed overview of SillaJen's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


SillaJen Business Description

Traded in Other Exchanges
N/A
Address
6F, 252, Geumjeong-ro, Geumjeong-gu, Busan, KOR, 46274
SillaJen Inc is a Korean based biotechnology company focused on engineering and developing cancer treatment cells. The company along with its subsidiary SillaJen Biotherapeutics, Inc offers Pexa-Vec, an oncolytic virus with antibodies, and improved survival in a randomized trial to cure cancer; and JX929, an engineered vaccinia virus strain that acts on cancer cells by viral attack and subsequent cancer cell oncolysis. SillaJen operates its business activities in Korea and United States.

SillaJen Headlines

No Headlines